The single-dose J&J vaccine had 67% efficacy against moderate to severe-critical COVID-19 at ≥14 d.
Where this comes from
- Record sourced from PubMed, PMID 34224270.
- Also identified by DOI 10.7326/ACPJ202107200-075.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Sadoff J, Gray G, Vandebosch A, et al. <b>Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19.</b> N Engl J Med. 2021. [Epub ahead of print.] 33882225.
Medical subject headings
- COVID-19
- Vaccines